Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Healthcare Providers Must Combine Zero Trust Architecture and Threat Modeling to Address Cybersecurity Challenges

Healthcare organizations face escalating cybersecurity threats that require a combined approach of zero trust architecture and threat modeling to effectively protect patient data. Layering continuous verification protocols with predictive security assessments enables providers to anticipate and mitigate risks before they materialize. This integrated strategy is increasingly essential as healthcare systems manage complex, interconnected digital environments.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Experts Talk on MarketScale.

By Mike Isbitski · FdaHealthcare CybersecurityHealthcare TechnologiesMike Isbitski
Share

Key takeaways

01

Zero trust architecture eliminates implicit trust and requires continuous verification of all users and devices accessing healthcare systems.

02

Threat modeling enables healthcare organizations to proactively identify vulnerabilities and prioritize security resources against likely attack vectors.

03

Combining zero trust with threat modeling creates a more resilient, layered defense for protecting sensitive patient data.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In today’s increasingly digital world, the healthcare sector faces significant cybersecurity challenges, necessitating urgent and sophisticated responses. The recent draft guidance issued by the FDA on cybersecurity for medical devices highlights a critical juncture for the industry: the need to implement and scale best practices in cybersecurity is more pressing than ever. As healthcare continues to integrate advanced technology, from medtech devices to comprehensive electronic health records, the potential for security breaches grows, underscoring the stakes involved in protecting sensitive health information.

What are the most effective strategies for healthcare organizations to not only implement but also scale and automate these cybersecurity best practices?

Mike Isbitski, the Director of Cybersecurity Strategy at Sysdig, shares his take on the imperative role of implementing and scaling cybersecurity best practices in the healthcare industry on an episode of Expert’s Talk. Isbitski emphasizes the importance of adopting a zero-trust architecture, threat modeling and enhancing supply chain security through comprehensive management of software and hardware components and more to tackle cybersecurity challenges in healthcare.

Isbitski emphasizes the importance of adopting a zero-trust architecture, threat modeling and enhancing supply chain security through comprehensive management of software and hardware components and more to tackle cybersecurity challenges in healthcare.

Here are the key takeaways from Isbitski’s analysis:

  • Zero Trust Architecture: Emphasizing the shift towards a zero trust framework, which is crucial for protecting against internal and external breaches.
  • Supply Chain Risks: Highlighting the importance of understanding and securing the supply chain, particularly with the use of Software and Hardware Bills of Materials (SBOMs and HBOMs) to manage risks effectively.
  • Regulatory Guidance: Discussing the new FDA cybersecurity guidelines, which aim to tailor cybersecurity measures specifically for the healthcare and medtech sectors.
  • Automation and Scalability: Addressing the critical need for cybersecurity strategies to be scalable and automated to handle the increasing volume and sophistication of threats.
  • Threat Modeling: Advocating for a proactive approach in threat modeling to anticipate and mitigate potential security threats before they materialize.
Video TranscriptExpand ↓

Yeah. I'd say it sometimes gets lumped under zero trust as an umbrella or maybe zero trust architecture. But, yeah, it's it's absolutely accurate, Doctor. Robin. Yeah, and the supply chain risk is definitely a big component of national cybersecurity strategy. Then technologically, that starts to get into bills of materials. You know? SBOM is usually one of the more well known, but, there's also hardware bombs. Right? Because specifically in this sector, right, with medtech and, you know, connected devices, that it's gonna look substantially different than just the software piece. So So now you have multiple bombs, and then you have to rationalize that. But are your providers even creating and maintaining them and then furnishing them to you? That's that's a big gap. Right? We have a lot of work to do there. I do like that the cybersecurity strategy called it out. The other thing I that I should call attention to is, like, the FDA. FDA just, issued cybersecurity guidance, draft guidance, on this topic. Right? So very specific to these industries. Right? It's, the technology is very much the same. Right? We're talking about segmentation, microsegmentation, access control, detection and response capabilities, you know, bills of materials, managing your suppliers. But how do you put that in the language of the specific health care industry or when you're dealing with, medical devices? So that draft guidance exists. You know, hopefully, that moves along very quickly, and then organizations start to adopt it. But, yeah, fundamentally, like, those security principles are there. We just we really need to start doing it. Right? We and then for myself, you know, kind of in my career, how I've approached the problem is, you know, if I get involved in a discussion on how I'm gonna solve a problem, it's kind of, well, how are we gonna scale this, and then how are we gonna automate it? Right? Because if you start pulling out a piece of paper and then you're expecting to track that, right, and this is going back twenty five years, I'm like, that's never gonna work. Right? And now, you know, twenty twenty four, it's like, there's no way. Like, so if you're doing that, you've already lost. So we we need to be thinking, you know, ten steps ahead, and then how are people gonna compromise this data? Right? You might say that's threat modeling and that that would be another concept within the cybersecurity strategies, but you you have to kinda retrain your brain to think that way.

Experts Talk

Part of this channel

Experts Talk

Industry experts debate the ideas that drive B2B decisions.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

MI
Mike Isbitski

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MI
Mike Isbitski

Director of Cybersecurity Strategy at Sysdig

Mike Isbitski is a cybersecurity strategist with deep expertise in zero trust architecture, cloud-native security, and application security. He has held advisory and strategy roles at organizations including Sysdig and TechTarget, focusing on helping enterprises navigate modern security challenges. Isbitski is a frequent speaker and contributor on topics including DevSecOps, API security, and threat modeling.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512